Atlas Lithium Corp (ATLX) Stock Price & Analysis
Atlas Lithium Corp (ATLX) rose 0.00% to USD 3.58 as of June 10, 2026 at 08:03 UTC, according to Nexqual real-time market data.
ATLX last closed at USD 3.58; the session ranged USD 3.44–3.85 on volume of 855,880 shares. Market capitalization is $105.58M, with a 52-week range of USD 3.44–8.25 (NCM). Source: Nexqual, June 10, 2026 at 08:03 UTC.
Key Statistics (as of June 10, 2026 at 08:03 UTC)
| Price | USD 3.58 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 3.58 |
| Open | USD 3.66 |
| Day Range | USD 3.44 – 3.85 |
| 52-Week Range | USD 3.44 – 8.25 |
| Volume | 855,880 shares |
| Market Cap | $105.58M |
| Exchange | NCM |
Technical Analysis (ATLX)
Nexqual's technical model rates ATLX "SELL" based on 1 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 08:03 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 34.5 (neutral) |
| vs SMA50 | Below (USD 4.67) |
| MACD | -0.28 (negative) |
Analyst Ratings (ATLX)
Wall Street analysts rate ATLX "None" based on 1 analysts, with a mean price target of USD 12.5 (range USD 12.5–12.5), per Nexqual as of June 10, 2026 at 08:03 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 12.5 |
| High Target | USD 12.5 |
| Low Target | USD 12.5 |
| Buy / Hold / Sell | 2 / 0 / 0 |
Earnings (ATLX)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-12-31 | USD -0.36 vs est -0.64 ▲ beat |
| 2025-09-30 | USD -0.35 vs est -0.64 ▲ beat |
| 2025-06-30 | USD -0.31 vs est -0.59 ▲ beat |
| 2025-03-31 | USD -0.55 vs est -0.5 ▼ miss |
Source: Nexqual, June 10, 2026 at 08:03 UTC.
Financials & Fundamentals (ATLX)
| Total Revenue | $141,702 |
|---|---|
| Revenue Growth (YoY) | +195.50% |
| Gross Margin | +53.13% |
| Operating Margin | -22574.73% |
| Profit Margin | +0.00% |
| ROE | -99.27% |
| Debt / Equity | 20.4 |
| Current Ratio | 2.52 |
| Total Cash | $34.36M |
| Total Debt | $10.76M |
| Free Cash Flow | $-23.18M |
Source: Nexqual, June 10, 2026 at 08:03 UTC.
Financial Health Score (ATLX)
Nexqual rates Atlas Lithium Corp's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 08:03 UTC.
| Growth | Critical — Revenue -86% YoY (annual), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $34M cash vs $11M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$23M, burning cash |
| Efficiency | Critical — ROE -99%, ROA -32.6% |
Ownership (ATLX)
| Insider Ownership | +29.00% |
|---|---|
| Institutional Ownership | +17.54% |
| Shares Outstanding | 29.49M |
| Float | 21.01M |
| Short % of Float | +7.67% |
Source: Nexqual, June 10, 2026 at 08:03 UTC.
Leadership (ATLX)
Atlas Lithium Corp is led by Marc Fogassa (age 58), Chairman, CEO & President, per Nexqual as of June 10, 2026 at 08:03 UTC.
| Chairman, CEO & President | Marc Fogassa (age 58) |
|---|---|
| CFO, Principal Accounting Officer & Treasurer | Tiago Moreira de Miranda (age 40) |
| Vice President of Investor Relations | Gary H. Guyton (age 58) |
| Vice President of Communications | Brian W. Bernier (age 67) |
Major Backers & Investors (ATLX)
Notable institutional backers of Atlas Lithium Corp include Citadel, Invesco, Marshall Wace LLP, according to Nexqual as of June 10, 2026 at 08:03 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Citadel | 23.34% |
| Invesco | 19.74% |
| Marshall Wace LLP | 16.88% |
| Waratah Capital Advisors Ltd. | 14.66% |
| Cross Staff Investments Inc. | 10.93% |
| Jane Street Group, LLC | 4.01% |
| Susquehanna International Group, LLP | 3.25% |
| GSA Capital Partners LLP | 2.75% |
Source: Nexqual, June 10, 2026 at 08:03 UTC.
From Atlas Lithium Corp's Latest SEC 10-K Filing (filed 2026-03-04)
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SGML | Sigma Lithium Corporation | USD 14.15 | ▲ 6.55% |
| BNZI | Banzai International, Inc. | USD 3.11 | ▲ 3.32% |
| FMST | Foremost Clean Energy Ltd. | USD 1.49 | ▼ 0.67% |
| VWAV | VisionWave Holdings, Inc. | USD 5.15 | ▼ 1.72% |
| BSEM | BioStem Technologies, Inc. | USD 3.52 | ▼ 9.65% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 08:03 UTC. This page is informational and not investment advice.